A DNA methylome profile of oligodendroglioma, IDH-mutant and 1p/19q-codeleted, a retained nuclear expression of ATRX and a TERT promoter mutation are desirable criteria (Table 2). The gene discussed is IDH2; the disease is oligodendroglioma.